Skip to main content
. Author manuscript; available in PMC: 2016 Jul 1.
Published in final edited form as: Early Hum Dev. 2015 May 15;91(7):387–392. doi: 10.1016/j.earlhumdev.2015.04.008

Table 5. Clinical adverse events.

Courses, n (%) N=490
Gastrointestinal
 Necrotizing enterocolitis–medical 8 (2)
 Necrotizing enterocolitis–surgical 1 (0.2)
 Focal intestinal perforation 1 (0.2)
Neurologic
 Intraventricular hemorrhage 2 (0.4)
 Periventricular leukomalacia 2 (0.4)
 Seizure 4 (1)
Cardiovascular
 Hypotension requiring pressors 57 (12)
Dermatologic
 Rash 7 (1)
Any clinical adverse event 70 (14)